Enzalutamide (enzalutamide) is currently produced and sold by several manufacturers

Enzalutamide, also known as enzalutamide, is a new androgen receptor inhibitor mainly used to treat castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC). At present, this drug has been officially launched in mainland China and has been included in the national medical insurance catalog. Patients can obtain it through regular hospitals and pharmacies.

In the Chinese market, the original drug of enzalutamide is jointly produced and sold by Astellas (Astellas) and Pfizer (Pfizer). As a domestically approved brand version, its specifications and efficacy are recognized by the national drug regulatory department. The common specifications on the market are 40mg tablets. The price of the whole box is about 4500 yuan, but the specific price will fluctuate according to the hospital and regional medical insurance policies. It is recommended to confirm the actual reimbursement price after medical insurance at the local hospital pharmacy.

In addition to the original drug, there are currently multiple versions of enzalutamide sold in foreign markets. Among them, the Turkish version of the original drug is more expensive, with each box selling for about 15,000 yuan. It is suitable for patients who are not sensitive to price and pursue the quality assurance of the original drug. In addition, some developing countries have launched versions of generic drugs, including generic drug manufacturers in Laos and India. These products are basically the same as the original drugs in terms of ingredients and clinical effects, but the price is more affordable, ranging from more than 1,000 yuan to several thousand yuan, making them suitable for patients with greater financial pressure.

Generally speaking, there are currently multiple manufacturers involved in the production and sales of enzalutamide around the world. Patients can choose domestic original drugs, overseas original drugs, or quality-qualified generic drugs for treatment based on their own economic status and treatment needs. When purchasing generic drugs, it is recommended to purchase them through formal channels and give priority to products produced by manufacturers with international certification to ensure efficacy and medication safety.

Reference materials:https://www.drugs.com/